Folgen
George A. Porter, Jr.
George A. Porter, Jr.
University of Rochester Medical Center
Bestätigte E-Mail-Adresse bei urmc.rochester.edu
Titel
Zitiert von
Zitiert von
Jahr
Caspases 3 and 7: key mediators of mitochondrial events of apoptosis
SA Lakhani, A Masud, K Kuida, GA Porter Jr, CJ Booth, WZ Mehal, I Inayat, ...
Science 311 (5762), 847-851, 2006
13782006
De novo mutations in histone-modifying genes in congenital heart disease
S Zaidi, M Choi, H Wakimoto, L Ma, J Jiang, JD Overton, ...
Nature 498 (7453), 220-223, 2013
9542013
De novo mutations in congenital heart disease with neurodevelopmental and other congenital anomalies
J Homsy, S Zaidi, Y Shen, JS Ware, KE Samocha, KJ Karczewski, ...
Science 350 (6265), 1262-1266, 2015
7572015
Contribution of rare inherited and de novo variants in 2,871 congenital heart disease probands
SC Jin, J Homsy, S Zaidi, Q Lu, S Morton, SR DePalma, X Zeng, H Qi, ...
Nature genetics 49 (11), 1593-1601, 2017
7202017
An uncoupling channel within the c-subunit ring of the F1FO ATP synthase is the mitochondrial permeability transition pore
KN Alavian, G Beutner, E Lazrove, S Sacchetti, HA Park, P Licznerski, ...
Proceedings of the National Academy of Sciences 111 (29), 10580-10585, 2014
6302014
The permeability transition pore controls cardiac mitochondrial maturation and myocyte differentiation
JR Hom, RA Quintanilla, DL Hoffman, KL de Mesy Bentley, JD Molkentin, ...
Developmental cell 21 (3), 469-478, 2011
3002011
Dystrophin colocalizes with beta-spectrin in distinct subsarcolemmal domains in mammalian skeletal muscle
GA Porter, GM Dmytrenko, JC Winkelmann, RJ Bloch
The Journal of cell biology 117 (5), 997-1005, 1992
2971992
Mitochondria as a drug target in ischemic heart disease and cardiomyopathy
AM Walters, GA Porter Jr, PS Brookes
Circulation research 111 (9), 1222-1236, 2012
2942012
Neuregulin-1 promotes formation of the murine cardiac conduction system
S Rentschler, J Zander, K Meyers, D France, R Levine, G Porter, ...
Proceedings of the National Academy of Sciences 99 (16), 10464-10469, 2002
2702002
SIRT3 deficiency exacerbates ischemia-reperfusion injury: implication for aged hearts
GA Porter, WR Urciuoli, PS Brookes, SM Nadtochiy
American Journal of Physiology-Heart and Circulatory Physiology 306 (12 …, 2014
2232014
The complex genetics of hypoplastic left heart syndrome
X Liu, H Yagi, S Saeed, AS Bais, GC Gabriel, Z Chen, KA Peterson, Y Li, ...
Nature genetics 49 (7), 1152-1159, 2017
1992017
Bioenergetics, mitochondria, and cardiac myocyte differentiation
GA Porter Jr, JR Hom, DL Hoffman, RA Quintanilla, KL de Mesy Bentley, ...
Progress in pediatric cardiology 31 (2), 75-81, 2011
1812011
The congenital heart disease genetic network study: rationale, design, and early results
Pediatric Cardiac Genomics Consortium, Writing Committee:, B Gelb, ...
Circulation research 112 (4), 698-706, 2013
1702013
Reduction in intracellular calcium levels inhibits myoblast differentiation
GA Porter, RF Makuck, SA Rivkees
Journal of Biological Chemistry 277 (32), 28942-28947, 2002
1472002
Regulation of mitochondrial fission by intracellular Ca2+ in rat ventricular myocytes
J Hom, T Yu, Y Yoon, G Porter, SS Sheu
Biochimica et Biophysica Acta (BBA)-Bioenergetics 1797 (6-7), 913-921, 2010
1412010
Influences of adenosine on the fetus and newborn
SA Rivkees, Z Zhao, G Porter, C Turner
Molecular genetics and metabolism 74 (1-2), 160-171, 2001
1182001
Genomic analyses implicate noncoding de novo variants in congenital heart disease
F Richter, SU Morton, SW Kim, A Kitaygorodsky, LK Wasson, KM Chen, ...
Nature genetics 52 (8), 769-777, 2020
1102020
Physiological roles of the mitochondrial permeability transition pore
N Mnatsakanyan, G Beutner, GA Porter, KN Alavian, EA Jonas
Journal of bioenergetics and biomembranes 49, 13-25, 2017
1102017
Cyclophilin D, somehow a master regulator of mitochondrial function
GA Porter Jr, G Beutner
Biomolecules 8 (4), 176, 2018
1022018
Cell death disguised: the mitochondrial permeability transition pore as the c-subunit of the F1FO ATP synthase
EA Jonas, GA Porter Jr, G Beutner, N Mnatsakanyan, KN Alavian
Pharmacological research 99, 382-392, 2015
972015
Das System kann den Vorgang jetzt nicht ausführen. Versuchen Sie es später erneut.
Artikel 1–20